Results 91 to 100 of about 2,801 (152)

[Modification of the prescription of anticholesteremic agents]. [PDF]

Aten Primaria, 2001
Luque Garrocho A, Hernández Jiménez MJ, Charques Velasco E, Alonso Martínez MM.   +3 more
europepmc   +1 more source

Comparative Effectiveness of Cholesteryl Ester Transfer Protein (CETP) Inhibitors on Lipid Profiles in Adults With Hyperlipidemia: A Comprehensive Systematic Review and Frequentist Network Meta-Analysis of Randomized Controlled Trials. [PDF]

Clin Cardiol
Khalil I, Islam MR, Promi SA, Joy AD, Sayed MA, Acharjee D, Al-Shammari AS, Abrar S, Jamil TB, Taseen M, Biswas S, Mifty SK, Al-Badri SG, Debnath A, Hossain MI, Akter M.   +15 more
europepmc   +1 more source

Does Rosuvastatin/Ezetimibe Combination Therapy Offer Potential Benefits for Glucose Metabolism beyond Lipid-Lowering Efficacy in T2DM? [PDF]

Diabetes Metab J
Park IR, Moon JS.
europepmc   +1 more source

Insights from Patients and Physicians About Use of Evolocumab for LDL-C Management. [PDF]

Adv Ther
Sidelnikov E, Jones LK, Debrosse A, Okorozo P, Kalich B.   +4 more
europepmc   +1 more source

Lomitapide response in a cohort of patients with homozygous familial hypercholesterolemia and the potential influence of MTTP gene variants. [PDF]

Orphanet J Rare Dis
Kolovou G, Kolovou V, Anagnostopoulou K, Anastasiou G, Kalogeropoulos P, Liberopoulos E.   +5 more
europepmc   +1 more source

LipidSnapshot - Treatment gaps in hypercholesterolemia in patients with atherosclerotic cardiovascular disease documented by office-based cardiologists and general practitioners in Germany. [PDF]

Clin Res Cardiol
Weingärtner O, Glück S, Werdan K, Schorr J, Thieme D, de la Llave A, von Vultée C, Haerer W.   +7 more
europepmc   +1 more source

Neuartige Lebensmittel [PDF]

, 1997
Geisen, Rolf, Holzapfel, Wilhelm Heinrich   +1 more
core  

Comparison of ezetimibe and atorvastatin versus atorvastatin alone on short-term major adverse cardiac events after percutaneous coronary intervention, a double-blind placebo-controlled randomized clinical trial. [PDF]

Trials
Farshidi H, Bijani B, Sobhani SA, Dastsouz F, Abbaszadeh S.   +4 more
europepmc   +1 more source

High-Intensity Statin versus Upfront Equivalent-Dose Combination of Moderate-Intensity Statin with Ezetimibe Following Acute Myocardial Infarction (ROSUZET-AMI): protocol of a multicentre, open-label, randomised non-inferiority trial. [PDF]

BMJ Open
Choo EH, Kim CJ, Hwang BH, Lee KY, Oh GC, Lim S, Choi IJ, Kim DB, Kwon OS, Lee S, Choi Y, Park CS, Park MW, Kim HY, Lee HC, Kang TS, Sung JK, Woo SI, Park HS, Yun KH, Chang K, ROSUZET-AMI investigator.   +21 more
europepmc   +1 more source

Challenges in the Choice of Nonstatin Medications for Low-Density Lipoprotein-C Lowering for Cardiovascular Risk Reduction. [PDF]

J Am Heart Assoc
Myerson M, Warden BA, Saseen JJ, Paparodis R.   +3 more
europepmc   +1 more source